Excerpt from: Telix Files TLX250-CDx (Zircaix®) BLA for Kidney Cancer Imaging
Excerpt from: Telix Files TLX250-CDx (Zircaix®) BLA for Kidney Cancer Imaging
Original post: Novartis intrathecal onasemnogene abeparvovec Phase III study meets primary endpoint in children and young adults with SMA
More here: European Commission approves RYBREVANT®▼ (amivantamab) in combination with LAZCLUZE®▼ (lazertinib) for the first-line treatment of patients with...
Go here to read the rest: Polyrizon Announces Publication of U.S. National Patent Application for Its Innovative Hydrogel Nasal Technologies
Read the original post: Chimerix Submits Dordaviprone New Drug Application for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma
View original post here: Recognition of the American Society of Clinical Oncology (ASCO) of the Liver Protective Effect of Can-Fite’s anti-Cancer Drug Namodenoson
Read more from the original source: Orion and Marinus terminate agreement for ganaxolone in Europe
The rest is here: Radiopharm Announces Strategic Co-Development Partnership with Lantheus for Australia
See the original post here: Hit Refresh in the New Year with Tilray's Premium Non-Alcohol Beverage Lineup
Read the original post: Biora Therapeutics Undertakes Chapter 11 Sale Process to Position Business for Future Growth
Recent Comments